Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Digestive Diseases (Basel, Switzerland)|March 31, 2016
The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of RifaximinFrancesca Romana Ponziani, Franco Scaldaferri, Valentina Petito, et al.
Langenbeck'S Archives of Surgery|November 16, 2023
Gastric cancer with peritoneal metastases: a single center outline and comparison of different surgical and intraperitoneal treatmentsFrancesco Santullo, Federica Ferracci, Carlo Abatini, et al.
Gastrointestinal Endoscopy|October 21, 2019
Accuracy of colon capsule endoscopy for advanced neoplasiaSilvia Pecere, Carlo Senore, Cesare Hassan, et al.
European Journal of Gastroenterology & Hepatology|December 22, 2023
Endoscopic full-thickness resection vs. endoscopic submucosal dissection of residual/recurrent colonic lesions on scars: a retrospective Italian and Japanese comparative studyFederico Barbaro, Luigi Giovanni Papparella, Michele Francesco Chiappetta, et al.
Expert Review of Gastroenterology & Hepatology|November 18, 2025
Measuring gut microbiome as a colorectal cancer screening tool: potential and challengesAndrea Severino, Stefano Andrea Marchitto, Piergiorgio Bisegna, et al.
Endoscopy|January 13, 2021
Colon capsule endoscopy in colorectal cancer screening: a systematic reviewFanny E R Vuik, Stella A V Nieuwenburg, Sarah Moen, et al.
Plos One|May 6, 2020
Esophageal microbiome signature in patients with Barrett's esophagus and esophageal adenocarcinomaLoris Riccardo Lopetuso, Marco Severgnini, Silvia Pecere, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 4, 2023
Dynamics of liver stiffness predicts complications in patients with HCV related cirrhosis treated with direct-acting antiviralsAlberto Nicoletti, Maria Elena Ainora, Marco Cintoni, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 20, 2024
A Predictive Model Based on Quantitative Fecal Immunochemical Test Can Stratify the Risk of Colorectal Cancer in an Organized Screening ProgramLeonardo Frazzoni, Silvia Pecere, Cesare Hassan, et al.
Plos One|October 27, 2017
Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with InfliximabFranco Scaldaferri, Daria D'Ambrosio, Grainne Holleran, et al.
Pageof 6